Literature DB >> 25376563

Pathomechanisms in heart failure: the contractile connection.

G J M Stienen1.   

Abstract

Heart failure is a multi-factorial progressive disease in which eventually the contractile performance of the heart is insufficient to meet the demands of the body, even at rest. A distinction can be made on the basis of the cause of the disease in genetic and acquired heart failure and at the functional level between systolic and diastolic heart failure. Here the basic determinants of contractile function of myocardial cells will be reviewed and an attempt will be made to elucidate their role in the development of heart failure. The following topics are addressed: the tension generating capacity, passive tension, the rate of tension development, the rate of ATP utilisation, calcium sensitivity of tension development, phosphorylation of contractile proteins, length dependent activation and stretch activation. The reduction in contractile performance during systole can be attributed predominantly to a loss of cardiomyocytes (necrosis), myocyte disarray and a decrease in myofibrillar density all resulting in a reduction in the tension generating capacity and likely also to a mismatch between energy supply and demand of the myocardium. This leads to a decline in the ejection fraction of the heart. Diastolic dysfunction can be attributed to fibrosis and an increase in titin stiffness which result in an increase in stiffness of the ventricular wall and hampers the filling of the heart with blood during diastole. A large number of post translation modifications of regulatory sarcomeric proteins influence myocardial function by altering calcium sensitivity of tension development. It is still unclear whether in concert these influences are adaptive or maladaptive during the disease process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25376563     DOI: 10.1007/s10974-014-9395-8

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  131 in total

Review 1.  The efficiency of muscle contraction.

Authors:  Nicholas P Smith; Christopher J Barclay; Denis S Loiselle
Journal:  Prog Biophys Mol Biol       Date:  2005-05       Impact factor: 3.667

2.  Measurement of myofilament calcium sensitivity at physiological temperature in intact cardiac trabeculae.

Authors:  Kenneth D Varian; Sripriya Raman; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05       Impact factor: 4.733

3.  Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.

Authors:  R J Solaro; A J Moir; S V Perry
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

4.  S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding.

Authors:  Jorge Alegre-Cebollada; Pallav Kosuri; David Giganti; Edward Eckels; Jaime Andrés Rivas-Pardo; Nazha Hamdani; Chad M Warren; R John Solaro; Wolfgang A Linke; Julio M Fernández
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

5.  Why does troponin I have so many phosphorylation sites? Fact and fancy.

Authors:  R John Solaro; Jolanda van der Velden
Journal:  J Mol Cell Cardiol       Date:  2010-02-25       Impact factor: 5.000

6.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

7.  Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts.

Authors:  Viola Kooij; Ronald J Holewinski; Anne M Murphy; Jennifer E Van Eyk
Journal:  J Mol Cell Cardiol       Date:  2013-04-22       Impact factor: 5.000

8.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

9.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Visualization of cardiac muscle thin filaments and measurement of their lengths by electron tomography.

Authors:  Thomas Burgoyne; Farina Muhamad; Pradeep K Luther
Journal:  Cardiovasc Res       Date:  2008-01-04       Impact factor: 10.787

View more
  7 in total

1.  Editorial on EMC 2014 special issue.

Authors:  Masataka Kawai; Graham Lamb; Stefan Galler
Journal:  J Muscle Res Cell Motil       Date:  2015-02       Impact factor: 2.698

Review 2.  Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration.

Authors:  Nicholas J Kaiser; Kareen L K Coulombe
Journal:  Biomed Mater       Date:  2015-05-13       Impact factor: 3.715

Review 3.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

4.  Posttranslational modifications of calcium/calmodulin-dependent protein kinase IIδ and its downstream signaling in human failing hearts.

Authors:  Tomas Rajtik; Eva Goncalvesova; Zoltan V Varga; Przemyslaw Leszek; Mariusz Kusmierczyk; Michal Hulman; Jan Kyselovic; Peter Ferdinandy; Adriana Adameova
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  Spontaneous myogenic fasciculation associated with the lengthening of cardiac muscle in response to static preloading.

Authors:  Shouyan Fan; Lingfeng Gao; Annie Christel Bell; Joseph Akparibila Azure; Yang Wang
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

6.  Engineered Cardiac Tissues Generated in the Biowire™ II: A Platform for Human-Based Drug Discovery.

Authors:  Nicole T Feric; Isabella Pallotta; Rishabh Singh; Danielle R Bogdanowicz; Marietta Gustilo; Khuram Chaudhary; Robert N Willette; Tim Chendrimada; Xiaoping Xu; Michael P Graziano; Roozbeh Aschar-Sobbi
Journal:  Toxicol Sci       Date:  2019-08-06       Impact factor: 4.849

7.  Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment.

Authors:  Ellen Quarles; Nathan Basisty; Ying Ann Chiao; Gennifer Merrihew; Haiwei Gu; Mariya T Sweetwyne; Jeanne Fredrickson; Ngoc-Han Nguyen; Maria Razumova; Kristina Kooiker; Farid Moussavi-Harami; Michael Regnier; Christopher Quarles; Michael MacCoss; Peter S Rabinovitch
Journal:  Aging Cell       Date:  2019-12-10       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.